Zelira product helping young patient with autism spectrum disorder
CEO Oludare Odumosu and Chairman Osagie Imasogie presentation at the Zelira AGM 2022
A Global Biopharmaceutical Company Developing and Marketing Clinically Validated Cannabinoid-Based Medicines
Zelira to launch a suite of new cannabinoid-based products in FY22 – Proactive
Zelira Therapeutics and Curtin University partner on research of proprietary technology that demonstrates significant uptake of CBD into the brain
Zelira Therapeutics Investor Slide Deck
Zelira Chairman Presentation at Cantor Fitzgerald International Cannabis Forum
Talking about the upcoming chronic pain clinical trial
Zelira Therapeutics are well positioned for ‘multiple product launches in 2021’